~~<i id='096CDB4FE4'><strike id='096CDB4FE4'><tt id='096CDB4FE4'><pre id='096CDB4FE4'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：explore 2025-09-13 15:22:35 Page View：39

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Arc Institute generative AI designs new CRISPR systems
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

explore

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Biden report: The neurospychology of memory and aging

PresidentBidenEvanVucci/APWhatistherelationshipbetweenaging,memoryloss,andoverallcognition?That’sama

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Glen Campbell's doctor discusses his public struggle with Alzheimer's

GlenCampbellperformsinIndio,Calif.,in2008.MichaelBuckner/GettyImagesGlenCampbell’sdecades-longmusica